ISMA-RHINA 2024
BackOAS 4 - Rhinosinusitis
Friday 06 Sep, 13:45 PM -
14:45 PM Helsinki, Finland
Fennia I
Oral Abstract Session
Abstract Text
13:45
OA16
Effects of Dupilumab on Eosinophil Subpopulations and Inflammation in Chronic Rhinosinusitis with Nasal Polyps
Abstract Text
13:57
OA17
Dupilumab Restores Barrier Function of Nasal Epithelial Cells and Decreases Type-2 Inflammatory Markers in Chronic Rhinosinusitis with Nasal Polyps
Abstract Text
14:09
OA18
Infection History and Risk of Chronic Inflammatory Airway Diseases; A Real-World Hospital Cohort Study
Abstract Text
14:21
OA19
Local nasal inflammation and postoperative wound healing is improved by postoperative doxycycline therapy after FESS in Chronic Rhinosinusitis patients
Abstract Text
14:33
OA20
Comparison of limited and complete endoscopic sinus surgery in CRSwNP - outcomes of 1-year follow-up
